Targeted polyethylene glycol gold nanoparticles for the treatment of pancreatic cancer: from synthesis to proof-of-concept in vitro studies

The main objective of this study was to optimize and characterize a drug delivery carrier for doxorubicin, intended to be intravenously administered, capable of improving the therapeutic index of the chemotherapeutic agent itself, and aimed at the treatment of pancreatic cancer. In light of this goal, we report a robust one-step method for the synthesis of dicarboxylic acid-terminated polyethylene glycol (PEG)-gold nanoparticles (AuNPs) and doxorubicin-loaded PEG-AuNPs, and their further antibody targeting (anti-Kv11.1 polyclonal antibody [pAb]). In in vitro proof-of-concept studies, we evaluated the influence of the nanocarrier and of the active targeting functionality on the anti-tumor efficacy of doxorubicin, with respect to its half-maximal effective concentration (EC50) and drug-triggered changes in the cell cycle. Our results demonstrated that the therapeutic efficacy of doxorubicin was positively influenced not only by the active targeting exploited through anti-Kv11.1-pAb but also by the drug coupling with a nanometer-sized delivery system, which indeed resulted in a 30-fold decrease of doxorubicin EC50, cell cycle blockage, and drug localization in the cell nuclei. The cell internalization pathway was strongly influenced by the active targeting of the Kv11.1 subunit of the human Ether-à-go-go related gene 1 (hERG1) channel aberrantly expressed on the membrane of pancreatic cancer cells. Targeted PEG-AuNPs were translocated into the lysosomes and were associated to an increased lysosomal function in PANC-1 cells. Additionally, doxorubicin release into an aqueous environment was almost negligible after 7 days, suggesting that drug release from PEG-AuNPs was triggered by enzymatic activity. Although preliminary, data gathered from this study have considerable potential in the application of safe-by-design nano-enabled drug-delivery systems (ie, nanomedicines) for the treatment of pancreatic cancer, a disease with a poor prognosis and one of the main current burdens of today’s health care bill of industrialized countries.

[1]  M. Ferrari,et al.  The nano-plasma interface: Implications of the protein corona. , 2014, Colloids and surfaces. B, Biointerfaces.

[2]  K. Ulbrich,et al.  Poly(ethylene glycol) multiblock copolymer as a carrier of anti-cancer drug doxorubicin. , 2000, Bioconjugate chemistry.

[3]  Harvey T. McMahon,et al.  Molecular mechanism and physiological functions of clathrin-mediated endocytosis , 2011, Nature Reviews Molecular Cell Biology.

[4]  S. Pispas,et al.  Advanced nanocarriers for an antitumor peptide , 2013, Journal of Nanoparticle Research.

[5]  S. Royle,et al.  Non-specificity of Pitstop 2 in clathrin-mediated endocytosis , 2014, Biology Open.

[6]  Lawrence Tamarkin,et al.  Phase I and Pharmacokinetic Studies of CYT-6091, a Novel PEGylated Colloidal Gold-rhTNF Nanomedicine , 2010, Clinical Cancer Research.

[7]  H. Maeda,et al.  The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo. , 2013, Advanced drug delivery reviews.

[8]  Glenn P. Goodrich,et al.  Evaluation of the Toxicity of Intravenous Delivery of Auroshell Particles (Gold–Silica Nanoshells) , 2012, International journal of toxicology.

[9]  Lisa Brannon-Peppas,et al.  Active targeting schemes for nanoparticle systems in cancer therapeutics. , 2008, Advanced drug delivery reviews.

[10]  P Ghaneh,et al.  Biology and management of pancreatic cancer , 2008, Postgraduate Medical Journal.

[11]  R. D. Shannon.  Revised effective ionic radii and systematic studies of interatomic distances in halides and chalcogenides , 1976 .

[12]  D. Astruc,et al.  Gold nanoparticles: assembly, supramolecular chemistry, quantum-size-related properties, and applications toward biology, catalysis, and nanotechnology. , 2004, Chemical reviews.

[13]  Jun-Sung Kim,et al.  Cellular uptake of magnetic nanoparticle is mediated through energy-dependent endocytosis in A549 cells , 2006, Journal of veterinary science.

[14]  Stefan A. Mann,et al.  hERG K(+) channels: structure, function, and clinical significance. , 2012, Physiological reviews.

[15]  C. Stournaras,et al.  Cell responses regulated by early reorganization of actin cytoskeleton , 2008, FEBS letters.

[16]  M. Conese,et al.  Role of clathrin- and caveolae-mediated endocytosis in gene transfer mediated by lipo- and polyplexes. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

[17]  J. Spadavecchia,et al.  New cysteamine based functionalization for biochip applications , 2009 .

[18]  R. Jain,et al.  Strategies for advancing cancer nanomedicine. , 2013, Nature materials.

[19]  Vijender Singh,et al.  How PEO-PPO-PEO triblock polymer micelles control the synthesis of gold nanoparticles: temperature and hydrophobic effects. , 2010, Langmuir : the ACS journal of surfaces and colloids.

[20]  Warren C W Chan,et al.  Nanoparticle-mediated cellular response is size-dependent. , 2008, Nature nanotechnology.

[21]  Chitta Ranjan Patra,et al.  Fabrication of gold nanoparticles for targeted therapy in pancreatic cancer. , 2010, Advanced drug delivery reviews.

[22]  David Goldstein,et al.  Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. , 2013, The New England journal of medicine.

[23]  C. Case,et al.  Understanding nanoparticle cellular entry: A physicochemical perspective. , 2015, Advances in colloid and interface science.

[24]  Jun-Jie Zhu,et al.  Gold Nanoparticle–Colloidal Carbon Nanosphere Hybrid Material: Preparation, Characterization, and Application for an Amplified Electrochemical Immunoassay , 2008 .

[25]  O. Shupliakov,et al.  Role of the Clathrin Terminal Domain in Regulating Coated Pit Dynamics Revealed by Small Molecule Inhibition , 2011, Cell.

[26]  Amplified plasmonic detection of DNA hybridization using doxorubicin-capped gold particles. , 2014, The Analyst.

[27]  J. Spadavecchia,et al.  Development of novel anti-Kv 11.1 antibody-conjugated PEG–TiO2 nanoparticles for targeting pancreatic ductal adenocarcinoma cells , 2013, Journal of Nanoparticle Research.

[28]  J. Ferlay,et al.  Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. , 2013, European journal of cancer.

[29]  M. Fukuda,et al.  Lysosomal membrane glycoproteins. Structure, biosynthesis, and intracellular trafficking. , 1991, The Journal of biological chemistry.

[30]  Qiuming Gong,et al.  Degradation of Trafficking-defective Long QT Syndrome Type II Mutant Channels by the Ubiquitin-Proteasome Pathway* , 2005, Journal of Biological Chemistry.

[31]  J. Lippincott-Schwartz,et al.  Brefeldin A: insights into the control of membrane traffic and organelle structure , 1992, The Journal of cell biology.

[32]  J. Yguerabide,et al.  Light-scattering submicroscopic particles as highly fluorescent analogs and their use as tracer labels in clinical and biological applications. , 1998, Analytical biochemistry.

[33]  P. Saftig,et al.  At the acidic edge: emerging functions for lysosomal membrane proteins. , 2003, Trends in cell biology.

[34]  Shigang Sun,et al.  Shape-controlled synthesis of gold nanoparticles in deep eutectic solvents for studies of structure-functionality relationships in electrocatalysis. , 2008, Angewandte Chemie.

[35]  Lauren A Austin,et al.  Exploiting the nanoparticle plasmon effect: observing drug delivery dynamics in single cells via Raman/fluorescence imaging spectroscopy. , 2013, ACS nano.

[36]  Gerd Ritter,et al.  PEGylated gold nanoparticles conjugated to monoclonal F19 antibodies as targeted labeling agents for human pancreatic carcinoma tissue. , 2008, ACS nano.

[37]  Eun Seong Lee,et al.  Polymeric nanovehicles for anticancer drugs with triggering release mechanisms , 2007 .

[38]  R. Jain,et al.  Challenges and key considerations of the enhanced permeability and retention effect for nanomedicine drug delivery in oncology. , 2013, Cancer research.

[39]  F. di Costanzo,et al.  hERG1 channels drive tumour malignancy and may serve as prognostic factor in pancreatic ductal adenocarcinoma , 2015, British Journal of Cancer.

[40]  Weihong Tan,et al.  Surface modification of silica nanoparticles to reduce aggregation and nonspecific binding. , 2006, Langmuir : the ACS journal of surfaces and colloids.

[41]  Sushovan Guha,et al.  Targeting pancreatic cancer with magneto-fluorescent theranostic gold nanoshells. , 2014, Nanomedicine.

[42]  Chun Li,et al.  Exceptionally high payload of doxorubicin in hollow gold nanospheres for near-infrared light-triggered drug release. , 2010, ACS nano.

[43]  K. Ulbrich,et al.  Polymeric drugs based on conjugates of synthetic and natural macromolecules. I. Synthesis and physico-chemical characterisation. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[44]  Li Wang,et al.  Type I Collagen-Mediated Synthesis and Assembly of UV-Photoreduced Gold Nanoparticles and Their Application in Surface-Enhanced Raman Scattering , 2007 .

[45]  A. Brown,et al.  Role of the Cytosolic Chaperones Hsp70 and Hsp90 in Maturation of the Cardiac Potassium Channel hERG , 2003, Circulation research.

[46]  R. Perez-soler,et al.  Cell cycle-dependent cytotoxicity, G2/M phase arrest, and disruption of p34cdc2/cyclin B1 activity induced by doxorubicin in synchronized P388 cells. , 1996, Molecular pharmacology.

[47]  Joseph M. DeSimone,et al.  Strategies in the design of nanoparticles for therapeutic applications , 2010, Nature Reviews Drug Discovery.

[48]  M. El-Sayed,et al.  Gold and silver nanoparticles in sensing and imaging: sensitivity of plasmon response to size, shape, and metal composition. , 2006, The journal of physical chemistry. B.

[49]  J. Olsen,et al.  The European Commission , 2020, The European Union.

[50]  R. Crowther,et al.  Structure and assembly of coated vesicles. , 1987, Annual review of biophysics and biophysical chemistry.

[51]  C. Murphy,et al.  pH-triggered assembly of gold nanorods. , 2005, Langmuir : the ACS journal of surfaces and colloids.

[52]  M. Wiemann,et al.  Interlaboratory comparison of size measurements on nanoparticles using nanoparticle tracking analysis (NTA) , 2013, Journal of Nanoparticle Research.

[53]  L. Howells,et al.  Pancreatic stellate cells and pancreas cancer: current perspectives and future strategies. , 2014, European journal of cancer.

[54]  Stephan Link,et al.  Optical properties and ultrafast dynamics of metallic nanocrystals. , 2003, Annual review of physical chemistry.

[55]  G. Basso,et al.  New Pyrimido-Indole Compound CD-160130 Preferentially Inhibits the KV11.1B Isoform and Produces Antileukemic Effects without Cardiotoxicity , 2015, Molecular Pharmacology.

[56]  R Jason Stafford,et al.  Feasibility study of particle-assisted laser ablation of brain tumors in orthotopic canine model. , 2009, Cancer research.

[57]  Luis M Liz-Marzán,et al.  Gemini-surfactant-directed self-assembly of monodisperse gold nanorods into standing superlattices. , 2009, Angewandte Chemie.

[58]  I. Pastan,et al.  Initial steps in receptor-mediated endocytosis. The influence of temperature on the shape and distribution of plasma membrane clathrin-coated pits in cultured mammalian cells. , 1984, Experimental cell research.

[59]  P. Jain,et al.  Calculated absorption and scattering properties of gold nanoparticles of different size, shape, and composition: applications in biological imaging and biomedicine. , 2006, The journal of physical chemistry. B.

[60]  A. Arcangeli,et al.  Potassium channels: novel emerging biomarkers and targets for therapy in cancer. , 2012, Recent patents on anti-cancer drug discovery.

[61]  B. Ghosh,et al.  Current trends in using polymer coated gold nanoparticles for cancer therapy. , 2015, International journal of pharmaceutics.

[62]  L. Lévy,et al.  Delivering nanomedicines to patients: a practical guide. , 2015, Nanomedicine : nanotechnology, biology, and medicine.

[63]  Z. Jia,et al.  Extracellular K+ concentration controls cell surface density of IKr in rabbit hearts and of the HERG channel in human cell lines. , 2009, The Journal of clinical investigation.

[64]  Rachel A. Kudgus,et al.  Tuning Pharmacokinetics and Biodistribution of a Targeted Drug Delivery System Through Incorporation of a Passive Targeting Component , 2014, Scientific Reports.

[65]  Chun Xing Li,et al.  Pharmacokinetics, clearance, and biosafety of polyethylene glycol-coated hollow gold nanospheres , 2014, Particle and Fibre Toxicology.

[66]  Leaf Huang,et al.  Pharmacokinetics and biodistribution of nanoparticles. , 2008, Molecular pharmaceutics.

[67]  S. Cheng,et al.  Gold-doxorubicin nanoconjugates for overcoming multidrug resistance. , 2012, Nanomedicine : nanotechnology, biology, and medicine.

[68]  Xiaohua Huang,et al.  Gold nanoparticles: Optical properties and implementations in cancer diagnosis and photothermal therapy , 2010 .

[69]  A. Arcangeli,et al.  hERG1 Potassium Channels: Novel Biomarkers in Human Solid Cancers , 2015, BioMed research international.

[70]  V. Aswal,et al.  Synthesis and characterization of high concentration block copolymer-mediated gold nanoparticles. , 2011, Langmuir : the ACS journal of surfaces and colloids.

[71]  J. Spadavecchia,et al.  The amphiphilic hydrophobin Vmh2 plays a key role in one step synthesis of hybrid protein-gold nanoparticles. , 2015, Colloids and surfaces. B, Biointerfaces.

[72]  S. Kornfeld,et al.  Asparagine-linked Oligosaccharides Protect Lamp-1 and Lamp-2 from Intracellular Proteolysis* , 1999, The Journal of Biological Chemistry.

[73]  W. Schneider-Brachert,et al.  Regulation of TNFR1 and CD95 signalling by receptor compartmentalization , 2008, Nature Reviews Molecular Cell Biology.

[74]  Martin G Pomper,et al.  State-of-the-art in design rules for drug delivery platforms: lessons learned from FDA-approved nanomedicines. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[75]  Carlos Cuevas,et al.  Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma. , 2012, Cancer cell.

[76]  Catherine J Murphy,et al.  Shape-dependent plasmon-resonant gold nanoparticles. , 2006, Small.

[77]  C. Murphy,et al.  Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. , 2005, Small.

[78]  A. P. Bell,et al.  A safe-by-design approach to the development of gold nanoboxes as carriers for internalization into cancer cells. , 2014, Biomaterials.

[79]  J. Reynolds,et al.  Nanomedicine applied to translational oncology: A future perspective on cancer treatment. , 2016, Nanomedicine : nanotechnology, biology, and medicine.

[80]  W. Roa,et al.  The biodistribution and pharmacokinetic evaluation of choline-bound gold nanoparticles in a human prostate tumor xenograft model. , 2013, Clinical and investigative medicine. Medecine clinique et experimentale.

[81]  J. Long,et al.  Stroma and pancreatic ductal adenocarcinoma: an interaction loop. , 2012, Biochimica et biophysica acta.

[82]  K. Ulbrich,et al.  Polymer conjugates of doxorubicin bound through an amide and hydrazone bond: Impact of the carrier structure onto synergistic action in the treatment of solid tumours. , 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[83]  Dermot Kelleher,et al.  Activation of stress-related signalling pathway in human cells upon SiO2 nanoparticles exposure as an early indicator of cytotoxicity , 2011, Journal of nanobiotechnology.

[84]  Rachael M. Crist,et al.  Autophagy and lysosomal dysfunction as emerging mechanisms of nanomaterial toxicity , 2012, Particle and Fibre Toxicology.

[85]  Elodie Boisselier,et al.  Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity. , 2009, Chemical Society reviews.

[86]  H. Pelham.  Multiple targets for brefeldin A , 1991, Cell.

[87]  D. Astruc,et al.  Gold Nanoparticles: Assembly, Supramolecular Chemistry, Quantum‐Size‐Related Properties, and Applications Toward Biology, Catalysis, and Nanotechnology. , 2004 .

[88]  Y. Barenholz.  Doxil®--the first FDA-approved nano-drug: lessons learned. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[89]  Kadir Aslan,et al.  Nanogold plasmon resonance-based glucose sensing. 2. Wavelength-ratiometric resonance light scattering. , 2005, Analytical chemistry.

[90]  Dong Liang,et al.  Influence of anchoring ligands and particle size on the colloidal stability and in vivo biodistribution of polyethylene glycol-coated gold nanoparticles in tumor-xenografted mice. , 2009, Biomaterials.

[91]  M. El-Sayed,et al.  Dependence of the enhanced optical scattering efficiency relative to that of absorption for gold metal nanorods on aspect ratio, size, end-cap shape, and medium refractive index. , 2005, The journal of physical chemistry. B.

[92]  Z. Tian,et al.  Au+-cetyltrimethylammonium bromide solution: A novel precursor for seed-mediated growth of gold nanoparticles in aqueous solution , 2012, Nano Research.